Floatz logo

Valganciclovir

Extramedullary Plasmacytoma

City of Hope Medical CenterSmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Extramedullary Plasmacytoma cohort.

Asset / SponsorPhaseRating
Inno-206
Stichting European Myeloma Network
Phase 3BB
DEXAMETHASONE
Stichting European Myeloma Network
Phase 3BB
Cyclophosphamide
Stichting European Myeloma Network
Phase 3BB
Bortezomib
Stichting European Myeloma Network
Phase 3BB
Evomela
Institute of Hematology & Blood Diseases Hospital, China
Phase 2B

View all 24 →

Same molecule, other indications

Valganciclovir is also rated in:

cytomegalovirus infectionDormant
BB
Indicative ·
68 / 100
View asset →
lymphoproliferative syndromeDormant
B
Indicative ·
61 / 100
View asset →
Epstein-Barr virus-associated lymphoproliferative disorderDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →